A detailed history of Ctc Capital Management, LLC transactions in Selecta Biosciences Inc stock. As of the latest transaction made, Ctc Capital Management, LLC holds 11,300 shares of SELB stock, worth $9,492. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,300
Holding current value
$9,492
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

BUY
$1.15 - $1.89 $12,994 - $21,357
11,300 New
11,300 $15,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Ctc Capital Management, LLC Portfolio

Follow Ctc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ctc Capital Management, LLC with notifications on news.